Previous 10 | Next 10 |
Summary BMRA continues to advance on its pipeline, building momentum around its IBS product and H.Pylori diagnostic test. Despite these tailwinds, the market's reaction has been muted to each, with the equilibrium in price action reached almost immediately. Investors are still posit...
Biomerica ( NASDAQ: BMRA ) stock rose ~6% on Thursday after the company said it received clearance from the Kingdom of Saudi Arabia Food and Drug Administration (KFDA) and the United Arab Emirates (UAE) Ministry of Health and Prevention (MOHAP) for its EZ Detect Colon Disease...
IRVINE, Calif., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq: BMRA) (the “Company”) received clearance from the Kingdom of Saudi Arabia Food and Drug Administration (KFDA), and the United Arab Emirates (UAE) Ministry of Health and Prevention (MOHAP) for the EZ Detect...
ACG Presidential Award Received for the InFoods ® IBS Data Presented at the American College of Gastroenterology (ACG) Annual Scientific Meeting The Presented Clinical Study Data Showed InFoods ® IBS Provided Significant Improvement in Several I...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Like a turbulent airplane ride, Biomerica (NASDAQ: BMRA ) suffered a seesaw over recent sessions. Initially, BMRA stock skyrocketed on Friday morning on news that Walmart (NYSE: WMT ) will sell the underlying compan...
Simple at-home device to increase sensitivity in breast self-exams Early detection of breast cancer saves lives About 80% of breast cancer is detected by women themselves who notice changes in their breast IRVINE, Calif., Oct. 14, 2022 (GLOBE NEWSWIRE) ...
Notice of Patent Allowance in Australia containing broad claims pertaining to treating ADD/ADHD using the InFoods ® Technology Notice of Patent Allowance in Japan containing broad claims pertaining to treating Depression using the InFoods ® Technology ...
Biomerica ( NASDAQ: BMRA ) on Thursday said its Aware Breast Self Exam device and its EZ Detect test for colorectal cancer were now being sold on Amazon.com ( AMZN ) and fulfilled by Amazon. BMRA's Aware is an at-home device to increase sensitivity in breast self exami...
Aware ® is a simple at-home device to increase sensitivity in breast self-exams. About 80% of breast cancer is detected by women themselves who notice changes in their breast. EZ Detect™ is a simple 2-minute, at-home test which detects an early warning ...
Summary Biomerica is one to keep a close eye on for the future. A lack of earnings momentum and bottom line fundamentals has us sitting on the sidelines. BMRA has upcoming inflection points with its InFoods and H. pylori segments. There are inherent risks in investing in s...
News, Short Squeeze, Breakout and More Instantly...
inFoods ® IBS patients can now conveniently self-collect a blood sample using a simple finger-stick methodology in the privacy of their home inFoods ® IBS test is the first of its kind to identify specific foods that can trigger an Irritable Bowel Syndrome (I...
Biomerica (NASDAQ: BMRA) , a biomedical technology company that develops, patents, manufactures and markets advanced diagnostics and therapeutic products, has entered into an at-market issuance sales agreement with EF Hutton LLC and R.F. Lafferty & Co. Inc. According to the company, the agree...
With IBS affecting 10 to 15% of the global population, the associated $21 billion in direct medical costs and absenteeism underscores the urgent need of innovative solutions. Recognized as the 7th most common diagnosis by all physicians, IBS represents a significant healthcare burden. inF...